ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

NCi Advisors Approve New SPORE Grant Program In Cancer Communications.

December 1, 2000

Holland, Leader Win $250,00 Milken Awards: Six Others Get $50,000 Prizes

December 9, 1988

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

L.A. County decides against Supporting New Cancer Hospital

February 4, 1977

ACS Plans 7 Hearings Around U.S. On cancer In The Disadvantaged

April 7, 1989

Radiation Dose Reconstruction Methods For Compensation Cases In Final Rule By HHS.

May 17, 2002